Johnson & Johnson (NYSE:JNJ) has announced that it will name its consumer health division ‘Kenvue.’
Earlier this year, GSK (NYSE:GSK) made a similar move by naming its consumer healthcare segment ‘Haleon.’ That moniker fuses the old English word ‘hale’ with the name ‘Leon.’ The first word means ‘healthy’ while the second refers to ‘strength.’
Haleon became a separate unit in July 2022.
Similarly, Kenvue brings together the words ‘ken,’ meaning ‘knowledge,’ and ‘vue,’ meaning ‘sight.’
Johnson & Johnson has signaled its intent to spin off Kenvue by November 2023.
The remaining company, headquartered in New Brunswick, New Jersey, would continue to focus on its drug and device businesses.
“Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation,” said Thibaut Mongon, CEO Designate, Kenvue, in a news release. “We breathe life into some of the world’s most iconic and belo…